Abbott Laboratories (NYSE:ABT) is one of the 7 Best Longevity Stocks to Buy Now. On June 7, 2026, Abbott Laboratories (NYSE:ABT) announced new data showing that diabetic ketoacidosis, or DKA, “remains
Abbott (ABT) closed the most recent trading day at $88.18, moving 1.64% from the previous trading session.
Insightful Moves in Elfun Trusts (Trades, Portfolio)' First Quarter 2026 N-PORT Filing
Abbott Laboratories (NYSE:ABT) is a deep value stock to invest in now. On June 3, Abbott Laboratories (NYSE:ABT) entered into an expanded agreement with MiniMed. The two are joining forces to commerci
Abbott Laboratories (NYSE:ABT) secured European CE Mark approval for Libre Duo, described as the world's first dual glucose and ketone continuous monitoring sensor. The company presented new data at t
In the most recent trading session, Abbott (ABT) closed at $89.17, indicating a -2.28% shift from the previous trading day.
ABT's Exact Sciences acquisition expands its cancer diagnostics portfolio as new data and screening guidelines strengthen growth prospects.
MDT trades at about 14x forward earnings with a 3.5% yield as fiscal 2027 guidance points to steady growth, but margins face tariffs and mix pressure.
View interactive chart, options flow, and AI analysis for ABT on Zorveq Finance.
Open ABT Chart & Analysis →